SMTL ID : 2rfn.1 (1 other biounit)

x-ray structure of c-Met with inhibitor.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x AM7: 2-benzyl-5-(3-fluoro-4-{[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxy}phenyl)-3-methylpyrimidin-4(3H)-one(Non-covalent)

AM7.1: 19 residues within 4Å: Chain A: I.38, F.43, V.46, A.62, K.64, F.78, E.81, G.82, M.85, L.94, L.96, V.109, L.111, P.112, Y.113, M.114, K.115, G.117, M.165 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:A.62, A:F.78, A:F.78, A:E.81, A:L.94, A:L.96, A:V.109, A:L.111, A:M.114 Hydrogen bonds: A:K.64, A:M.114 pi-Stacking: A:F.43

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bellon, S.F. et al., c-Met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutations. J.Biol.Chem. (2008)

Release Date

2007-11-06

Peptides

Hepatocyte growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Hepatocyte growth factor receptor

Related Entries With Identical Sequence